The £180 million Biomedical Catalyst, announced by David Cameron in December 2011, will see the Medical Research Council and the Technology Strategy Board working together to provide responsive and effective support for the best life science opportunities arising in the UK.
Support through the Biomedical Catalyst is available to UK businesses (SMEs) and academics looking to develop innovative solutions to healthcare challenges either individually or in collaboration.
This joint programme between the MRC and TSB will offer three categories of grant:
Early Stage Award
Late Stage Award
The categories are designed to support the maturation of an idea from concept to commercialisation. This will create a pipeline of projects encompassing the early stage exploration of commercial and technical potential through to proving utility in the field (which may involve human clinical trials) and development prior to commercialisation. Applicants may apply for the award category most appropriate for their work without having received a prior award.
Support will be available for projects arising from any sector or discipline that are aimed at addressing healthcare challenges. Example solutions may include (but are not limited to): stratified healthcare (both therapy and diagnostic components), regenerative medicine, diagnostics, eHealth and mHealth solutions, enabling medical technologies and devices. The Biomedical Catalyst will seek to support those opportunities which demonstrate the highest scientific and commercial potential irrespective of medical area.
Please see the Technology Strategy Board healthcare page for more information about their work in this area.
The Biomedical Catalyst will operate in response mode and will in essence be “always open”. However to assist the processing of applications there will be key submission and assessment dates which will differ depending on the category of award and applicant type, please see the links/dates below for further details. The assessment of Early and Late Stage awards will culminate in a panel assessment for both academic and business led applications enabling funding decisions to be made three times a year.
All applications will be subject to assessment by independent expert reviewers with short-listed applicants for Late Stage Awards being interviewed by a committee. Applicants for Late Stage Awards are advised to note that should they be successful in being invited to interview they should hold the dates of the next committee meetings as these are fixed and non-negotiable. Dates will be confirmed when applicants are sent their invitation to submit a full stage proposal (and will be posted on this page in due course).
Please note: If your application is led by an academic, you will need to apply on the Medical Research Council website.
If your application is led by a business, you should make your application on the TSB website.
Open date: 30 April 2012
The RKE Operations team can help you with your application.